Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium
ConditionEmergence Delirium
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age2-6
SponsorKasr El Aini Hospital
About this trial
Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups.
Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)
Eligibility criteria
Qualifiers
Scheduled for elective cardiac catheterization under general anesthesia.
Disqualifiers
neurological disorder, psychiatric disease, or current psychoactive medication.
allergy.
significant systemic comorbidities.
Trial design
Treatments tested in this trial
- Dexmedetomidine and Midazolam
- Ketamine and Midazolam
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov